Concurrent use may increase risk of mucosal ulceration or ischemic colitis. Avoid concurrent use.
Source: NLP:polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored
Brand names: Gavilyte-N
Osmotic Laxative · Osmotic Activity
Route: Oral
Contraindications
4 CONTRAINDICATIONS Gastrointestinal (GI) obstruction, ileus, or gastric retention ( 4 , 5.6 ) Bowel perforation ( 4 , 5.6 ) Toxic colitis or toxic megacolon ( 4 ) Known allergy or hypersensitivity to components of GaviLyte-N ( 4 , 11 ) GaviLyte-N is contraindicated in the following conditions: Gastrointestinal (GI) obstruction, ileus, or gastric retention Bowel perforation Toxic colitis or toxic megacolon Known allergy or hypersensitivity to any component of GaviLyte-N for oral solution [see How Supplied/Storage and Handling (16) ]
Pregnancy & Breastfeeding
8.1 Pregnancy Animal reproduction studies have not been conducted with GaviLyte-N. It is also not known whether GaviLyte-N can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. GaviLyte-N should be given to a pregnant woman only if clearly needed.
2 interactions on record
Concurrent use may increase risk of mucosal ulceration or ischemic colitis. Avoid concurrent use.
Source: NLP:polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored
Concurrent use may increase risk of mucosal ulceration or ischemic colitis. Avoid concurrent use.
Source: NLP:polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored